MEI Pharma Balance Sheet Health
Financial Health criteria checks 6/6
MEI Pharma has a total shareholder equity of $34.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $134.2M and $99.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$112.04m |
| Equity | US$34.35m |
| Total liabilities | US$99.83m |
| Total assets | US$134.19m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MMI0's short term assets ($120.5M) exceed its short term liabilities ($23.6M).
Long Term Liabilities: MMI0's short term assets ($120.5M) exceed its long term liabilities ($76.2M).
Debt to Equity History and Analysis
Debt Level: MMI0 is debt free.
Reducing Debt: MMI0 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MMI0 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: MMI0 has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 17.3% each year.